Clinical data suggest that, compared with those in patients with inactive SLE and healthy individuals, the expression of S100A8 and S100A9 in patients with active SLE is significantly elevated and positively correlated with systemic lupus erythematosus disease activity index (SLEDAI) scores [28, 29]. Here, S100A9 is linked to systemic lupus erythematosus.